Sign in

CIK 0001360214

  • Large accelerated filer

HARROW, INC.

Sign in to watch
Ticker
HROW
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
450567010
Phone
+1 615-733-4731
Business address
1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
Former names
HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
  1. 4 Derivatives Options or other derivatives
  2. 4 Option exercise Chief Financial Officer acquired 39,000 shares (option exercise)
  3. 4 Option exercise Chief Executive Officer acquired 156,000 shares (option exercise)
  4. 4 Open-market sale Director sold 6,500 shares at $4.75 ($30,875)
  5. 4 Open-market sale Director sold 6,500 shares at $5.25 ($34,125)
  6. 4 Open-market sale Director sold 6,500 shares at $5.67 ($36,855)
  7. 4 Open-market sale Director sold 6,500 shares at $6.89 ($44,785)
  8. 4 Open-market sale Director sold 6,500 shares at $7.91 ($51,415)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale Director sold 10,000 shares at $5.78 ($57,800)
  14. 4 Open-market sale Director sold 10,000 shares at $4.57 ($45,700)
  15. 4 Open-market sale Director sold 10,000 shares at $4.77 ($47,700)
  16. 4 Open-market sale Director sold 10,000 shares at $6.91 ($69,100)
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market sale Director sold 10,000 shares at $5.86 ($58,600)

Page 8 of 15 · 296 filings